Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
Taiwan · Delayed Price · Currency is TWD 34.40
-1.10 (-3.10%)
Oct 8, 2026, 2:59 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 1.56 billion as of October 9, 2026. It is the 30,606th most valuable company in the world and the 1,813th biggest in Taiwan. Its market cap has increased by 82.01% in one year.
Market Cap
1.56B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,813 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 12, 2023, TPEX:6917's market cap has increased from 1.11B to 1.56B, an increase of 40.27%. That is a compound annual growth rate of 9.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.56B | 41.56% |
| Dec 31, 2025 | 1.10B | 43.17% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
| Jan 12, 2023 | 1.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 1.93B |
| Anti-Microbial Savior BioteQ | 1.89B |
| U-Neuron Biomedical | 1.86B |
| Sunny Pharmtech | 1.82B |
| Synbio Tech | 1.73B |
| TaiRx | 1.63B |
| Greenyn Biotechnology | 1.57B |
| GenMont Biotech Incorporation | 1.46B |